. Carboplatine, 10 mg/ml, Teva ® Classics

N. Abbott, A. Patabendige, D. Dolman, S. Yusof, and D. Begley, Structure and function of the blood???brain barrier, Neurobiology of Disease, vol.37, issue.1, pp.13-25, 2010.
DOI : 10.1016/j.nbd.2009.07.030

N. Abbott, L. Ronnback, and E. Hansson, Astrocyte???endothelial interactions at the blood???brain barrier, Nature Reviews Neuroscience, vol.15, issue.1, pp.41-53, 2006.
DOI : 10.1046/j.1469-7580.2002.00065.x

J. Adam, M. Biston, A. Joubert, A. Charvet, L. Bas et al., Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood???brain barrier disruption: Quantitative iodine biodistribution studies and associated dosimetry, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.4, pp.1173-82, 2005.
DOI : 10.1016/j.ijrobp.2004.12.026
URL : https://hal.archives-ouvertes.fr/inserm-00388910

F. Adams, A. Norman, R. Mello, and D. Bass, Effect of Radiation and Contrast Media on Chromosomes, Radiology, vol.124, issue.3, pp.823-829, 1977.
DOI : 10.1148/124.3.823

T. Aida and W. Bodell, Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines, Cancer Res, vol.47, pp.1361-1367, 1987.

N. Allen and B. Barres, Neuroscience: Glia ??? more than just brain glue, Nature, vol.86, issue.7230, pp.675-677, 2009.
DOI : 10.1038/457675a

D. Arifin, K. Lee, C. Wang, and K. Smith, Role of Convective Flow in Carmustine Delivery to a Brain Tumor, Pharmaceutical Research, vol.58, issue.10, pp.2289-302, 2009.
DOI : 10.1007/s11095-009-9945-8

R. Barth, Rat brain tumor models in experimental neuro-oncology: the 9L RT-2 and CNS-1 gliomas, Journal of Neuro-Oncology, vol.36, issue.1, pp.91-102, 1998.
DOI : 10.1023/A:1005805203044

R. Barth, Boron neutron capture therapy at the crossroads: Challenges and opportunities, Applied Radiation and Isotopes, vol.67, issue.7-8, pp.3-6, 2009.
DOI : 10.1016/j.apradiso.2009.03.102

R. Barth and B. Kaur, Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas, Journal of Neuro-Oncology, vol.10, issue.Suppl 1, pp.299-312, 2009.
DOI : 10.1007/s11060-009-9875-7

M. Bellavance, M. Blanchette, and D. Fortin, Recent Advances in Blood???Brain Barrier Disruption as a CNS Delivery Strategy, The AAPS Journal, vol.10, issue.1, pp.166-77, 2008.
DOI : 10.1208/s12248-008-9018-7

S. Berry, T. Loh, T. Yan, and T. Kinsella, Role of MutSalpha in the recognition of iododeoxyuridine in DNA, Cancer Res, vol.63, pp.5490-5495, 2003.

R. Bhattacharya and P. Mukherjee, Biological properties of ???naked??? metal nanoparticles???, Advanced Drug Delivery Reviews, vol.60, issue.11, 2008.
DOI : 10.1016/j.addr.2008.03.013

M. Biston, Radio-chimiothérapie par photoactivation synchrotron de drogues platinées anticancéreuses, 2004.

M. Biston, A. Joubert, J. Adam, H. Elleaume, S. Bohic et al., Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis-Platinum and Irradiated with Monochromatic Synchrotron X-Rays, Cancer Research, vol.64, issue.7, pp.2317-2340, 2004.
DOI : 10.1158/0008-5472.CAN-03-3600
URL : https://hal.archives-ouvertes.fr/inserm-00388956

W. Bodell, K. Tokuda, and D. Ludlum, Differences in DNA alkylation products formed in sensitive and resistant human glioma cells treated with N-(2-chloroethyl)-N-nitrosourea, Cancer Res, vol.48, pp.4489-92, 1988.

E. Boisselier and D. Astruc, Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity, Chemical Society Reviews, vol.301, issue.1, pp.1759-82, 2009.
DOI : 10.1186/1477-3155-6-2

C. Boudou, J. Balosso, F. Esteve, and H. Elleaume, Monte Carlo dosimetry for synchrotron stereotactic radiotherapy of brain tumours, Physics in Medicine and Biology, vol.50, issue.20, pp.4841-51, 2005.
DOI : 10.1088/0031-9155/50/20/007
URL : https://hal.archives-ouvertes.fr/inserm-00388924

M. Bredel and J. Zentner, Brain-tumour drug resistance: the bare essentials, The Lancet Oncology, vol.3, issue.7, pp.397-406, 2002.
DOI : 10.1016/S1470-2045(02)00786-6

S. Brown, P. Nativo, J. Smith, D. Stirling, P. Edwards et al., Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin, Journal of the American Chemical Society, vol.132, issue.13, pp.4678-4684, 2010.
DOI : 10.1021/ja908117a

E. Brun, L. Sanche, and C. Sicard-roselli, Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution, Colloids and Surfaces B: Biointerfaces, vol.72, issue.1, pp.128-162, 2009.
DOI : 10.1016/j.colsurfb.2009.03.025

J. Cadet, M. Berger, T. Douki, and J. Ravanat, Oxidative damage to DNA: Formation, measurement, and biological significance, Rev Physiol Biochem Pharmacol, vol.131, pp.1-87, 1997.
DOI : 10.1007/3-540-61992-5_5

J. Cadet, T. Douki, S. Frelon, S. Sauvaigo, J. Pouget et al., Assessment of oxidative base damage to isolated and cellular DNA by HPLC-MS/MS measurement1,2 1This article is part of a series of reviews on ???Oxidative DNA Damage and Repair.??? The full list of papers may be found on the homepage of the journal. 2Guest Editor: Miral Dizdaroglu, Free Radical Biology and Medicine, vol.33, issue.4, pp.441-450, 2002.
DOI : 10.1016/S0891-5849(02)00820-1

J. Cadet, T. Douki, D. Gasparutto, and J. Ravanat, Oxidative damage to DNA: formation, measurement and biochemical features, Mutat Res, vol.531, pp.5-23, 2003.
DOI : 10.1142/p607

A. Carpentier, La chirurgie des gliomes c??r??braux en 2008, Cancer/Radioth??rapie, vol.12, issue.6-7, pp.676-686, 2008.
DOI : 10.1016/j.canrad.2008.09.005

M. Chang, A. Shiau, Y. Chen, C. Chang, H. Chen et al., Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice, Cancer Science, vol.55, issue.7, pp.1479-84, 2008.
DOI : 10.1021/nl052396o

M. Chatel, M. Lebrun, C. Fauchon, and F. , Gliomes de haut grade : astrocytomes anaplasiques et glioblastomes, EMC - Neurologie, vol.2, issue.3, pp.257-278, 2005.
DOI : 10.1016/j.emcn.2004.12.002

B. Chithrani, J. Stewart, C. Allen, and D. Jaffray, Intracellular uptake, transport, and processing of nanostructures in cancer cells, Nanomedicine: Nanotechnology, Biology and Medicine, vol.5, issue.2, pp.118-145, 2009.
DOI : 10.1016/j.nano.2009.01.008

D. Chithrani, S. Jelveh, F. Jalali, M. Van-prooijen, C. Allen et al., Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy, Radiation Research, vol.173, issue.6, pp.719-747, 2010.
DOI : 10.1667/RR1984.1

S. Cho, TH-C-T-6C-04: Estimation of Tumor Dose Enhancement Due to Gold Nanoparticles During Typical Radiation Treatments: A Preliminary Monte Carlo Study, Medical Physics, vol.32, issue.6, pp.2162-2162, 2005.
DOI : 10.1118/1.1998660

S. Cho, Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study, Physics in Medicine and Biology, vol.50, issue.15, pp.163-73, 2005.
DOI : 10.1088/0031-9155/50/15/N01

J. Cook, J. Glass, R. Lebovics, H. Bobo, H. Pass et al., Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine, Cancer Res, vol.52, pp.719-744, 1992.

S. Corde, A. Joubert, J. Adam, A. Charvet, L. Bas et al., Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds, British Journal of Cancer, vol.83, issue.3, pp.544-51, 2004.
DOI : 10.1088/0031-9155/44/8/306

P. Dawson, M. Penhaligon, E. Smith, and J. Saunders, Synergistic Cytotoxicity of Iodinated Contrast Agents and X-Radiation, Investigative Radiology, vol.23, issue.1, pp.110-113, 1988.
DOI : 10.1097/00004424-198809001-00012

D. Jong, W. Hagens, W. Krystek, P. Burger, M. Sips et al., Particle size-dependent organ distribution of gold nanoparticles after intravenous administration, Biomaterials, vol.29, issue.12, pp.1912-1921, 2008.
DOI : 10.1016/j.biomaterials.2007.12.037

J. Degen, S. Walbridge, A. Vortmeyer, E. Oldfield, and R. Lonser, Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats, Journal of Neurosurgery, vol.99, issue.5, pp.893-901, 2003.
DOI : 10.3171/jns.2003.99.5.0893

B. Denny, R. Wheelhouse, M. Stevens, L. Tsang, and J. Slack, NMR and Molecular Modeling Investigation of the Mechanism of Activation of the Antitumor Drug Temozolomide and Its Interaction with DNA, Biochemistry, vol.33, issue.31, pp.9045-9051, 1994.
DOI : 10.1021/bi00197a003

S. Doblas, T. He, D. Saunders, J. Pearson, J. Hoyle et al., Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography, Journal of Magnetic Resonance Imaging, vol.19, issue.2, pp.267-75, 2010.
DOI : 10.1002/jmri.22263

F. Doetsch, The glial identity of neural stem cells, Nature Neuroscience, vol.6, issue.11, pp.1127-1161, 2003.
DOI : 10.1038/nn1144

A. Doiron, D. Yapp, M. Olivares, J. Zhu, and S. Lehnert, Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine, Cancer Res, vol.59, pp.3677-81, 1999.

M. Dolan and A. Pegg, O6-benzylguanine and its role in chemotherapy, Clin Cancer Res, vol.3, pp.837-884, 1997.

F. Ducray, Biologie des gliomes c??r??braux, Cancer/Radioth??rapie, vol.12, issue.6-7, pp.663-668, 2008.
DOI : 10.1016/j.canrad.2008.09.001

J. Dugas, M. Varnes, E. Sajo, C. Welch, K. Ham et al., Dependence of Cell Survival on IUdR Concentration in 35 keV Photon-activated Auger Electron Radiotherapy, International Journal of Radiation Oncology Biology Physics, 2010.

L. Eccles, M. Lomax, O. Neill, and P. , Hierarchy of lesion processing governs the repair, double-strand break formation and mutability of three-lesion clustered DNA damage, Nucleic Acids Research, vol.38, issue.4, pp.1123-1157, 2010.
DOI : 10.1093/nar/gkp1070

M. Edouard, Dosimétrie par radiothérapie stéréotaxique par rayonnement synchrotron : d'une vision macroscopique à des considérations microscopiques des dépôts d'énergie, 2010.

M. Edouard, D. Broggio, Y. Prezado, F. Esteve, H. Elleaume et al., Treatment plans optimization for contrast-enhanced synchrotron stereotactic radiotherapy, Medical Physics, vol.68, issue.6, pp.2445-56, 2010.
DOI : 10.1118/1.3327455
URL : https://hal.archives-ouvertes.fr/inserm-00589257

M. Esteller, Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents, New England Journal of Medicine, vol.343, issue.343, pp.1740-1740, 2000.

A. Fornace, J. Dobson, P. Kinsella, and T. , Enhancement of radiation damage in cellular dna following unifilar substitution with iododeoxyuridine, International Journal of Radiation Oncology*Biology*Physics, vol.18, issue.4, pp.873-881, 1990.
DOI : 10.1016/0360-3016(90)90410-L

N. Franken, H. Rodermond, J. Stap, J. Haveman, and C. Van-bree, Clonogenic assay of cells in vitro, Nature Protocols, vol.19, issue.5, pp.2315-2324, 2006.
DOI : 10.1080/095530097143653

H. Friedman, T. Kerby, and H. Calvert, Temozolomide and treatment of malignant glioma, Clinical Cancer Research, vol.6, pp.2585-2597, 2000.

A. Georgakilas, Processing of DNA damage clusters in human cells: current status of knowledge, Mol. BioSyst., vol.156, issue.suppl., pp.30-35, 2008.
DOI : 10.1016/j.freeradbiomed.2007.10.045

D. Giljohann, D. Seferos, W. Daniel, M. Massich, P. Patel et al., Gold Nanoparticles for Biology and Medicine, Angewandte Chemie International Edition, vol.131, issue.19, pp.3280-94, 2010.
DOI : 10.1002/anie.200904359

M. Guarnieri, B. Carson, A. Khan, M. Penno, and G. Jallo, Flexible versus rigid catheters for chronic administration of exogenous agents into central nervous system tissues, Journal of Neuroscience Methods, vol.144, issue.2, pp.147-52, 2005.
DOI : 10.1016/j.jneumeth.2004.10.019

A. Guliaev, B. Singer, and H. B. , Chloroethylnitrosourea-derived ethano cytosine and adenine adducts are substrates for Escherichia coli glycosylases excising analogous etheno adducts, DNA Repair, vol.3, issue.10, pp.1311-1332, 2004.
DOI : 10.1016/j.dnarep.2004.04.015

J. Hainfeld, F. Dilmanian, D. Slatkin, and H. Smilowitz, Radiotherapy enhancement with gold nanoparticles, Journal of Pharmacy and Pharmacology, vol.169, issue.8, pp.977-85, 2008.
DOI : 10.1211/jpp.60.8.0005

J. Hainfeld, D. Slatkin, T. Focella, and H. Smilowitz, Gold nanoparticles: a new X-ray contrast agent, The British Journal of Radiology, vol.79, issue.939, pp.248-53, 2006.
DOI : 10.1259/bjr/13169882

J. Hainfeld, D. Slatkin, and H. Smilowitz, The use of gold nanoparticles to enhance radiotherapy in mice, Physics in Medicine and Biology, vol.49, issue.18, pp.309-324, 2004.
DOI : 10.1088/0031-9155/49/18/N03

A. Hall and M. Tilby, Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies, Blood Reviews, vol.6, issue.3, pp.163-73, 1992.
DOI : 10.1016/0268-960X(92)90028-O

C. Hartinger, Y. Tsybin, J. Fuchser, and P. Dyson, Characterization of Platinum Anticancer Drug Protein-Binding Sites Using a Top-Down Mass Spectrometric Approach, Inorganic Chemistry, vol.47, issue.1, pp.17-26, 2008.
DOI : 10.1021/ic702236m

M. Hegi, A. Diserens, T. Gorlia, M. Hamou, N. De-tribolet et al., Gene Silencing and Benefit from Temozolomide in Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.997-1003, 2005.
DOI : 10.1056/NEJMoa043331

J. Hoeijmakers, Genome maintenance mechanisms for preventing cancer, Nature, vol.411, issue.6835, pp.366-74, 2001.
DOI : 10.1038/35077232

H. Ide and M. Kotera, Human DNA Glycosylases Involved in the Repair of Oxidatively Damaged DNA, Biological & Pharmaceutical Bulletin, vol.27, issue.4, pp.480-485, 2004.
DOI : 10.1248/bpb.27.480

H. Ikushima, Radiation therapy: state of the art and the future, The Journal of Medical Investigation, vol.57, issue.1,2, pp.1-11, 2010.
DOI : 10.2152/jmi.57.1

K. Iwamoto, S. Cochran, J. Winter, E. Holburt, R. Higashida et al., Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors, Radiotherapy and Oncology, vol.8, issue.2, pp.161-70, 1987.
DOI : 10.1016/S0167-8140(87)80170-6

A. Iyer, G. Khaled, J. Fang, and H. Maeda, Exploiting the enhanced permeability and retention effect for tumor targeting, Drug Discovery Today, vol.11, issue.17-18, pp.812-820, 2006.
DOI : 10.1016/j.drudis.2006.07.005

W. Jahnen-dechent and U. Simon, Function follows form: shape complementarity and nanoparticle toxicity, Nanomedicine, vol.3, issue.5, pp.601-604, 2008.
DOI : 10.2217/17435889.3.5.601

K. Jennette, S. Lippard, G. Vassiliades, and W. Bauer, Metallointercalation Reagents. 2-Hydroxyethanethiolato(2,2',2''-terpyridine)-platinum(II) Monocation Binds Strongly to DNA By Intercalation, Proceedings of the National Academy of Sciences, vol.71, issue.10, pp.3839-3882, 1974.
DOI : 10.1073/pnas.71.10.3839

H. Johnston, G. Hutchison, F. Christensen, S. Peters, S. Hankin et al., A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity, Critical Reviews in Toxicology, vol.91, issue.4, pp.328-374, 2010.
DOI : 10.1002/smll.200800922

Y. Jung and S. Lippard, Direct cellular responses to platinum-induced DNA damage, 2007.

S. Kaneko, N. Clendenon, and M. Kartha, Experimental Study in a Rat Brain Tumor by Combined Treatment with cis-DDP and Irradiation, Neurologia medico-chirurgica, vol.23, issue.12, pp.917-940, 1983.
DOI : 10.2176/nmc.23.917

S. Karnas, E. Yu, R. Mcgarry, and J. Battista, Optimal photon energies for IUdR K-edge radiosensitization with filtered x-ray and radioisotope sources, Physics in Medicine and Biology, vol.44, issue.10, pp.2537-2586, 1999.
DOI : 10.1088/0031-9155/44/10/312

A. Kassis, P. Wen, A. Van-den-abbeele, J. Baranowska-kortylewicz, G. Makrigiorgos et al., 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats, J Nucl Med, vol.39, pp.1148-54, 1998.

S. Kawabata, S. Miyatake, N. Nonoguchi, R. Hiramatsu, K. Iida et al., Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients, Applied Radiation and Isotopes, vol.67, issue.7-8, 2009.
DOI : 10.1016/j.apradiso.2009.03.015

L. Kelland, The resurgence of platinum-based cancer chemotherapy, Nature Reviews Cancer, vol.110, issue.8, pp.573-84, 2007.
DOI : 10.1038/nrc2167

D. Khuntia, W. Tome, and M. Mehta, Radiation techniques in neuro-oncology, Neurotherapeutics, vol.175, issue.Suppl 2, pp.487-499, 2009.
DOI : 10.1016/j.nurt.2009.04.009

T. Kinsella, Coordination of DNA Mismatch Repair and Base Excision Repair Processing of Chemotherapy and Radiation Damage for Targeting Resistant Cancers, Clinical Cancer Research, vol.15, issue.6, pp.1853-1862, 2009.
DOI : 10.1158/1078-0432.CCR-08-1307

D. Klyachko, M. Huels, and L. Sanche, Halogen Anion Formation in 5-Halouracil Films: X Rays Compared to Subionization Electrons, Radiation Research, vol.151, issue.2, pp.177-87, 1999.
DOI : 10.2307/3579768

L. Ko, A. Koestner, and W. Wechsler, Morphological characterization of nitrosourea-induced glioma cell lines and clones, Acta Neuropathologica, vol.26, issue.1, pp.23-31, 1980.
DOI : 10.1007/BF00688846

T. Kong, J. Zeng, X. Wang, X. Yang, Y. J. Mcquarrie et al., Enhancement of Radiation Cytotoxicity in Breast-Cancer Cells by Localized Attachment of Gold Nanoparticles, Small, vol.311, issue.9, pp.1537-1580, 2008.
DOI : 10.1002/smll.200700794

N. Laperriere, L. Zuraw, and G. Cairncross, Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review, Radiotherapy and Oncology, vol.64, issue.3, pp.259-273, 2002.
DOI : 10.1016/S0167-8140(02)00078-6

B. Laster, W. Thomlinson, and R. Fairchild, Photon Activation of Iododeoxyuridine: Biological Efficacy of Auger Electrons, Radiation Research, vol.133, issue.2, pp.219-243, 1993.
DOI : 10.2307/3578359

T. Lawrence, M. Davis, J. Maybaum, P. Stetson, and W. Ensminger, The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure, International Journal of Radiation Oncology*Biology*Physics, vol.18, issue.6, pp.1393-1401, 1990.
DOI : 10.1016/0360-3016(90)90313-9

C. Liu, C. Wang, S. Chen, H. Chen, W. Leng et al., Enhancement of cell radiation sensitivity by pegylated gold nanoparticles, Physics in Medicine and Biology, vol.55, issue.4, pp.931-976, 2010.
DOI : 10.1088/0031-9155/55/4/002

D. Ludlum, The Chloroethylnitrosoureas: Sensitivity and Resistance to Cancer Chemotherapy at the Molecular Level, Cancer Investigation, vol.105, issue.6, pp.588-98, 1997.
DOI : 10.1021/jm00029a005

J. Mcdonald, S. See, I. Tremont, H. Colman, M. Gilbert et al., The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors, Cancer, vol.161, issue.7, pp.1468-1477, 2005.
DOI : 10.1002/cncr.21338

A. Mesa, A. Norman, T. Solberg, J. Demarco, and J. Smathers, Dose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents, Physics in Medicine and Biology, vol.44, issue.8, pp.1955-68, 1999.
DOI : 10.1088/0031-9155/44/8/308

M. Middleton and G. Margison, Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway, The Lancet Oncology, vol.4, issue.1, pp.37-44, 2003.
DOI : 10.1016/S1470-2045(03)00959-8

Y. Nakagawa, T. Kageji, Y. Mizobuchi, and H. Kumada, Clinical results of BNCT for malignant brain tumors in children, Applied Radiation and Isotopes, vol.67, issue.7-8, pp.27-30, 2009.
DOI : 10.1016/j.apradiso.2009.03.090

R. Nath, P. Bongiorni, and S. Rockwell, Enhancement of iudr radiosensitization by low energy photons, International Journal of Radiation Oncology*Biology*Physics, vol.13, issue.7, pp.1071-1080, 1987.
DOI : 10.1016/0360-3016(87)90047-2

D. Noll, T. Mason, and P. Miller, Formation and Repair of Interstrand Cross-Links in DNA, Chemical Reviews, vol.106, issue.2, pp.277-301, 2006.
DOI : 10.1021/cr040478b

A. Norman, F. Adams, and R. Riley, Cytogenetic Effects of Contrast Media and Triiodobenzoic Acid Derivatives in Human Lymphocytes, Radiology, vol.129, issue.1, pp.199-203, 1978.
DOI : 10.1148/129.1.199

A. Norman, M. Ingram, R. Skillen, D. Freshwater, K. Iwamoto et al., X-ray phototherapy for canine brain masses, Radiation Oncology Investigations, vol.22, issue.1, pp.8-14, 1997.
DOI : 10.1002/(SICI)1520-6823(1997)5:1<8::AID-ROI2>3.0.CO;2-1

H. Ohgaki and P. Kleihues, Genetic alterations and signaling pathways in the evolution of gliomas, Cancer Science, vol.3, issue.12, pp.2235-2276, 2009.
DOI : 10.1111/j.1349-7006.2009.01308.x

Y. Pan, S. Neuss, A. Leifert, M. Fischler, F. Wen et al., Size-Dependent Cytotoxicity of Gold Nanoparticles, Small, vol.32, issue.11, pp.1941-1950, 2007.
DOI : 10.1002/smll.200700378

D. Parsons, S. Jones, X. Zhang, J. Lin, R. Leary et al., An Integrated Genomic Analysis of Human Glioblastoma Multiforme, Science, vol.321, issue.5897, pp.1807-1819, 2008.
DOI : 10.1126/science.1164382

J. Perry, A. Chambers, K. Spithoff, and N. Laperriere, Gliadel?? Wafers in the Treatment of Malignant Glioma: A Systematic Review, Current Oncology, vol.14, issue.5, pp.189-94, 2007.
DOI : 10.3747/co.2007.147

B. Petri, A. Bootz, A. Khalansky, T. Hekmatara, R. Muller et al., Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants, Journal of Controlled Release, vol.117, issue.1, pp.51-59, 2007.
DOI : 10.1016/j.jconrel.2006.10.015

J. Pressacco, D. Hedley, and C. Erlichman, ICI D1694 and idoxuridine: a synergistic antitumor combination, Cancer Res, vol.54, pp.3772-3780, 1994.

C. Rabik and M. Dolan, Molecular mechanisms of resistance and toxicity associated with platinating agents, Cancer Treatment Reviews, vol.33, issue.1, pp.9-23, 2007.
DOI : 10.1016/j.ctrv.2006.09.006

W. Rahman, N. Bishara, T. Ackerly, C. He, P. Jackson et al., Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy, Nanomedicine: Nanotechnology, Biology and Medicine, vol.5, issue.2, pp.136-142, 2009.
DOI : 10.1016/j.nano.2009.01.014

S. Rapoport, Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications, Cellular and Molecular Neurobiology, vol.20, issue.2, pp.217-247, 2000.
DOI : 10.1023/A:1007049806660

T. Reithmeier, E. Graf, T. Piroth, M. Trippel, M. Pinsker et al., BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors, BMC Cancer, vol.52, issue.1, p.30, 2010.
DOI : 10.1023/A:1010624504311

R. Rodriguez, M. Ritter, J. Fowler, and T. Kinsella, Kinetics of cell labelling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo, International Journal of Radiation Oncology*Biology*Physics, vol.29, issue.1, pp.105-118, 1994.
DOI : 10.1016/0360-3016(94)90232-1

J. Rose, A. Norman, M. Ingram, C. Aoki, T. Solberg et al., First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx), International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.5, pp.1127-1159, 1999.
DOI : 10.1016/S0360-3016(99)00347-8

M. Rothenberg, Topoisomerase I inhibitors: review and update, Annals of Oncology, vol.8, issue.9, pp.837-55, 1997.
DOI : 10.1023/A:1008270717294

J. Rousseau, Chimio-radiothérapie des tumeurs cérébrales : intérêt de l'injection, 2007.

J. Rousseau, R. Barth, M. Fernandez, J. Adam, J. Balosso et al., Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors, Journal of Neuro-Oncology, vol.110, issue.3, pp.287-95, 2010.
DOI : 10.1007/s11060-009-0074-3
URL : https://hal.archives-ouvertes.fr/inserm-00622594

J. Rousseau, R. Barth, M. Moeschberger, and H. Elleaume, Efficacy of Intracerebral Delivery of Carboplatin in Combination With Photon Irradiation for Treatment of F98 Glioma-Bearing Rats, International Journal of Radiation Oncology*Biology*Physics, vol.73, issue.2, pp.530-536, 2009.
DOI : 10.1016/j.ijrobp.2008.09.018
URL : https://hal.archives-ouvertes.fr/inserm-00410447

J. Rousseau, C. Boudou, R. Barth, J. Balosso, F. Esteve et al., Enhanced Survival and Cure of F98 Glioma Bearing Rats following Intracerebral Delivery of Carboplatin in Combination with Photon Irradiation, Clinical Cancer Research, vol.13, issue.17, pp.5195-201, 2007.
DOI : 10.1158/1078-0432.CCR-07-1002
URL : https://hal.archives-ouvertes.fr/inserm-00410458

J. Rousseau, C. Boudou, F. Esteve, and H. Elleaume, Convection-Enhanced Delivery of an Iodine Tracer Into Rat Brain for Synchrotron Stereotactic Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.3, pp.943-51, 2007.
DOI : 10.1016/j.ijrobp.2007.01.065
URL : https://hal.archives-ouvertes.fr/inserm-00383882

R. Safaei, Role of copper transporters in the uptake and efflux of platinum containing drugs, Cancer Letters, vol.234, issue.1, pp.34-43, 2006.
DOI : 10.1016/j.canlet.2005.07.046

S. Samnick, B. Romeike, T. Lehmann, I. Israel, R. C. Mautes et al., Efficacy of Systemic Radionuclide Therapy with p-131I-Iodo-L-Phenylalanine Combined with External Beam Photon Irradiation in Treating Malignant Gliomas, Journal of Nuclear Medicine, vol.50, issue.12, pp.2025-2057, 2009.
DOI : 10.2967/jnumed.109.066548

N. Sanai and M. Berger, Operative techniques for gliomas and the value of extent of resection, Neurotherapeutics, vol.62, issue.3, pp.478-486, 2009.
DOI : 10.1016/j.nurt.2009.04.005

S. Mello, R. Callisen, H. Winter, J. Kagan, A. Norman et al., Radiation dose enhancement in tumors with iodine, Medical Physics, vol.10, issue.1, pp.75-83, 1983.
DOI : 10.1118/1.595378

O. Scharer, Chemistry and Biology of DNA Repair, Angewandte Chemie International Edition, vol.42, issue.26, pp.2946-74, 2003.
DOI : 10.1002/anie.200200523

J. Seibert and J. Boone, X-ray imaging physics for nuclear medicine technologists. Part 2: X-ray interactions and image formation, J Nucl Med Technol, vol.33, pp.3-18, 2005.

K. Shinohara, H. Nakano, and H. Ohara, Detection of Auger Enhancement Induced in Hela Cells Labeled with Iododeoxyuridine and Irradiated with 150 Kv X-Rays: Effects of Cysteamine and Dimethylsulfoxide, Acta Oncologica, vol.336, issue.7, pp.869-75, 1996.
DOI : 10.2307/3575380

T. Solberg, K. Iwamoto, and A. Norman, Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumours, Physics in Medicine and Biology, vol.37, issue.2, pp.439-482, 1992.
DOI : 10.1088/0031-9155/37/2/010

G. Sonavane, K. Tomoda, and K. Makino, Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size, Colloids and Surfaces B: Biointerfaces, vol.66, issue.2, pp.274-80, 2008.
DOI : 10.1016/j.colsurfb.2008.07.004

D. Song and R. Lonser, Convection-Enhanced Delivery for the Treatment of Pediatric Neurologic Disorders, Journal of Child Neurology, vol.23, issue.10, pp.1231-1238, 2008.
DOI : 10.1177/0883073808321064

R. Stupp, Un guide pratique au traitement des gliomes, Bulletin du Cancer, vol.94, pp.817-822, 2007.

J. Swenberg, A. Koestner, W. Wechsler, and R. Denlinger, Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats, Cancer Res, vol.32, pp.2656-60, 1972.

W. Tong, M. Kirk, and D. Ludlum, Formation of the cross-link 1-[N3-deoxycytidyl),2- [N1-deoxyguanosinyl]ethane in DNA treated with N,N'-bis(2-chloroethyl)-N-nitrosourea, Cancer Res, vol.42, pp.3102-3107, 1982.

M. Tubiana, Radiobiologie Radiothérapie et radioprotection Bases fondamentales, 2008.

D. Turner, S. Cortellino, J. Schupp, E. Caretti, T. Loh et al., The DNA N-Glycosylase MED1 Exhibits Preference for Halogenated Pyrimidines and Is Involved in the Cytotoxicity of 5-Iododeoxyuridine, Cancer Research, vol.66, issue.15, pp.7686-93, 2006.
DOI : 10.1158/0008-5472.CAN-05-4488

E. Van-meir, C. Hadjipanayis, A. Norden, H. Shu, P. Wen et al., Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma, CA: A Cancer Journal for Clinicians, vol.60, issue.3, pp.166-193, 2010.
DOI : 10.3322/caac.20069

J. Voges, R. Reszka, A. Gossmann, C. Dittmar, R. Richter et al., Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma, Annals of Neurology, vol.98, issue.4, pp.479-87, 2003.
DOI : 10.1002/ana.10688

D. Wang and A. Bordey, The astrocyte odyssey, Progress in Neurobiology, vol.86, pp.342-67, 2008.
DOI : 10.1016/j.pneurobio.2008.09.015

P. Wen and S. Kesari, Malignant Gliomas in Adults, New England Journal of Medicine, vol.359, issue.5, pp.492-507, 2008.
DOI : 10.1056/NEJMra0708126

J. Williams, X. Yuan, L. Dillehay, V. Shastri, H. Brem et al., Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma, International Journal of Radiation Oncology*Biology*Physics, vol.42, issue.3, pp.631-640, 1998.
DOI : 10.1016/S0360-3016(98)00258-2

Q. Wu, M. Guarnieri, B. Tyler, R. Clatterbuck, Y. Liu et al., Section on tumors: Young Investigator Award: Local release of carboplatin via an Alzet mini-osmotic pump prolongs survival in a rat brainstem tumor model, Clin Neurosurg, vol.51, pp.332-341, 2004.

H. Yan, D. Parsons, J. G. Mclendon, R. Rasheed, B. Yuan et al., Mutations in Gliomas, New England Journal of Medicine, vol.360, issue.8, pp.765-73, 2009.
DOI : 10.1056/NEJMoa0808710

W. Yang, T. Huo, R. Barth, N. Gupta, M. Weldon et al., Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors, J Neurooncol. Tables des matières, issue.1, 2010.

I. Traitement-des-gliomes-de-haut-grade and .. , 15 III.A. Neurochirurgie des tumeurs cérébrales : développements récents, p.16

.. Contexte-de-l-'étude and I. , 89 II. 5-iodo-2, 90 II.A. Incorporation de l'IUdR dans l, p.92

I. Lésions-de-l-'adn and .. , 186 III.A. Synthèse des standards des adduits platinés, p.186